Clin2
NCT07000747Possibly a fitRecruiting

Dengue and sickle cell disease study

Dengue (Virus); Fever, SandflySickle Cell Disease

Part of Blood & lymphatic, Genetic & congenital, Infections clinical trials.

This study looks at how severe dengue fever affects people with sickle cell disease. It aims to understand why some people with sickle cell get very sick from dengue and how their cells react.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
130 people
Ages
6 years to 25 years
Study type
Observational

Who can take part

  • You have sickle cell disease (SS or SC type) or normal hemoglobin (AA).
  • You are between 6 and 25 years old.
  • You have been stable for the last month without any sickle cell crisis or blood transfusion in the last 3 months.
  • You are being treated for sickle cell disease at the Guadeloupe Sickle Cell Center.
  • You or your legal representative can sign a consent form to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07187973Recruiting· Phase 1
Study of DISC-3405 for people with sickle cell disease

This trial tests an investigational drug called DISC-3405 in people with sickle cell disease (SCD) to see if it is safe and how it affects your body. It may be an option if you have certain SCD complications or lab results.

Birmingham, Alabama
NCT02824471Recruiting
Testing a chip technology for sickle cell samples

This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.

Cleveland, Ohio
NCT07000318Not yet recruiting· Early Phase 1
CS-206 for sickle cell disease in teens

This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.

Shanghai, Shanghai Municipality
NCT04055818Recruiting· Phase 1
Testing three medicines for high-risk sickle cell disease

This Phase 1 study tests whether nicotinamide, oral tetrahydrouridine, and decitabine can help people with high-risk sickle cell disease. It is mainly a safety-and-dosing study, but it also looks for signs the medicines may improve disease-related problems.

Chicago, Illinois
NCT00047996Enrolling by invitation
Blood Donation Study for Blood Vessel Research

This study collects blood and urine samples from adults to help researchers understand diseases affecting blood vessels. Your donation helps scientists develop better treatments.

Bethesda, Maryland
NCT05170412Recruiting
Diet habits study for adults with sickle cell disease

This study asks adults with sickle cell disease about what they eat and their eating routines. The goal is to understand diet patterns in sickle cell and how they may relate to health, which could help future care and guidance.

Bethesda, Maryland

Hear when a new Sickle Cell Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.